 Women who endure medical abortions with the pills mifepristone and misoprostol have no greater risk of experiencing a tubal pregnancy or miscarriage in future pregnancies than women who endure surgical abortions.
Food and Drug Administration in 2000 endorsed Mifeprex – known generally as mifepristone – to be taken in combination with the drug misoprostol to persuade a medical abortion at up to 49 days’. It has been estimated that about 8% to 10% of all abortions in the U.S. are medical abortions.
The scientists discovered that tubal pregnancies, during which a fertilized egg implants outside the uterus, happened in about 2.5% of women in both the medical abortion and surgical abortion groups. The study also discovered approximately 12% of the women in both groups experienced a miscarriage. Women in the medical abortion group had a little lower risk of giving birth ahead of time or of having a low-birthweight infant, but the dissimilarity was not statistically significant.
The scientists took into the consideration at only the first pregnancy after the abortion and did not evaluate pregnancy results between women who had a medical abortion and women who had never had an abortion. The scientists reported that women who have never had an abortion often have different incomes, smoking rates and other health-related behaviors that would make it complicated to compare them to women who had abortions.
| 
